News
The American Academy of Pediatrics lit the fuse in 2023. Their recommendation to use GLP-1 weight-loss drugs in children and adolescents wasn’t just a nod to pharmaceutical innovation — it was a ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
17h
Newsner on MSNStudy reveals surprising twist after quitting weight loss medsA new study reveals that after discontinuation of popular weight loss drugs like Ozempic and Wegovy, the body may respond in a dramatic and unexpected way – and it’s a heavy twist that most users ...
Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results